feed,title,long_url,short_url
Barron's,"FDA Panel Is a Win for Pfizer, Despite Mixed Result, Analyst Says",https://www.barrons.com/articles/pfizer-stock-fda-covid-51632145613?mod=RTA,https://j.mp/2XA80ji
